[HTML][HTML] Glycogen synthase kinase-3 signaling in Alzheimer's disease
E Lauretti, O Dincer, D Praticò - … et Biophysica Acta (BBA)-Molecular Cell …, 2020 - Elsevier
Alzheimer's disease (AD) is the most common form of neurodegenerative disorder with
dementia, accounting for approximately 70% of the all cases. Currently, 5.8 million people in …
dementia, accounting for approximately 70% of the all cases. Currently, 5.8 million people in …
Therapeutic strategies for Alzheimer's disease in clinical trials
Alzheimer's disease (AD) is considered to be the most common cause of dementia and is an
incurable, progressive neurodegenerative disorder. Current treatment of the disease …
incurable, progressive neurodegenerative disorder. Current treatment of the disease …
Diet in the prevention of Alzheimer's disease: current knowledge and future research requirements
O Stefaniak, M Dobrzyńska, S Drzymała-Czyż… - Nutrients, 2022 - mdpi.com
Alzheimer's disease is a progressive brain disease that is becoming a major health problem
in today's world due to the aging population. Despite it being widely known that diet has a …
in today's world due to the aging population. Despite it being widely known that diet has a …
Alzheimer's disease: a review from the pathophysiology to diagnosis, new perspectives for pharmacological treatment
P dos Santos, C Leide, PF Ozela… - Current medicinal …, 2018 - ingentaconnect.com
Dementia is characterized by the impairment of cognition and behavior of people over 65
years. Alzheimer's disease (AD) is the most prevalent neurodegenerative disorder in the …
years. Alzheimer's disease (AD) is the most prevalent neurodegenerative disorder in the …
Aging microglia—phenotypes, functions and implications for age-related neurodegenerative diseases
B Spittau - Frontiers in aging neuroscience, 2017 - frontiersin.org
Aging of the central nervous system (CNS) is one of the major risk factors for the
development of neurodegenerative pathologies such as Parkinson's disease (PD) and …
development of neurodegenerative pathologies such as Parkinson's disease (PD) and …
Dietary patterns and Alzheimer's disease: an updated review linking nutrition to neuroscience
Alzheimer's disease (AD) is a growing concern for the aging population worldwide. With no
current cure or reliable treatments available for AD, prevention is an important and growing …
current cure or reliable treatments available for AD, prevention is an important and growing …
PSEN1ΔE9, APPswe, and APOE4 confer disparate phenotypes in human iPSC-derived microglia
H Konttinen, S Ohtonen, S Wojciechowski… - Stem cell reports, 2019 - cell.com
Here we elucidate the effect of Alzheimer disease (AD)-predisposing genetic backgrounds,
APOE4, PSEN1ΔE9, and APPswe, on functionality of human microglia-like cells (iMGLs) …
APOE4, PSEN1ΔE9, and APPswe, on functionality of human microglia-like cells (iMGLs) …
Protective effect of amyloid-β peptides against herpes simplex virus-1 infection in a neuronal cell culture model
Senile amyloid plaques are one of the main hallmarks of Alzheimer's disease (AD). They
correspond to insoluble deposits of amyloid-ß peptides (Aß) and are responsible for the …
correspond to insoluble deposits of amyloid-ß peptides (Aß) and are responsible for the …
Revisiting the blood-brain barrier: A hard nut to crack in the transportation of drug molecules
Barriers are the hallmark of a healthy physiology, blood-brain barrier (BBB) being a tough
nut to crack for most of the antigens and chemical substances. The presence of tight …
nut to crack for most of the antigens and chemical substances. The presence of tight …
Mutations in presenilin 2 and its implications in Alzheimer's disease and other dementia-associated disorders
Y Cai, SSA An, SY Kim - Clinical interventions in aging, 2015 - Taylor & Francis
Alzheimer's disease (AD) is the most common form of dementia. Mutations in the genes
encoding presenilin 1 (PSEN1), presenilin 2 (PSEN2), and amyloid precursor protein have …
encoding presenilin 1 (PSEN1), presenilin 2 (PSEN2), and amyloid precursor protein have …